Future IL-6 studies in native atrial and ventricular cardiomyocytes and animal models of lipotoxicity are critical for fundamental insights into the functional consequence of IL-6 modulation of Na current in metabolic disease-related arrhythmias. This evidence concerns the gene IL6 and Other metabolic disease.